These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 34364222)

  • 1. Elaboration of a benzofuran scaffold and evaluation of binding affinity and inhibition of Escherichia coli DsbA: A fragment-based drug design approach to novel antivirulence compounds.
    Duncan LF; Wang G; Ilyichova OV; Dhouib R; Totsika M; Scanlon MJ; Heras B; Abbott BM
    Bioorg Med Chem; 2021 Sep; 45():116315. PubMed ID: 34364222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Fragment-Based Development of a Benzofuran Hit as a New Class of
    Duncan LF; Wang G; Ilyichova OV; Scanlon MJ; Heras B; Abbott BM
    Molecules; 2019 Oct; 24(20):. PubMed ID: 31635355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of fragment-based screening to the design of inhibitors of Escherichia coli DsbA.
    Adams LA; Sharma P; Mohanty B; Ilyichova OV; Mulcair MD; Williams ML; Gleeson EC; Totsika M; Doak BC; Caria S; Rimmer K; Horne J; Shouldice SR; Vazirani M; Headey SJ; Plumb BR; Martin JL; Heras B; Simpson JS; Scanlon MJ
    Angew Chem Int Ed Engl; 2015 Feb; 54(7):2179-84. PubMed ID: 25556635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of Diverse DsbA Enzymes in Multi-DsbA Encoding Pathogens.
    Totsika M; Vagenas D; Paxman JJ; Wang G; Dhouib R; Sharma P; Martin JL; Scanlon MJ; Heras B
    Antioxid Redox Signal; 2018 Sep; 29(7):653-666. PubMed ID: 29237285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peptide inhibitors of the Escherichia coli DsbA oxidative machinery essential for bacterial virulence.
    Duprez W; Premkumar L; Halili MA; Lindahl F; Reid RC; Fairlie DP; Martin JL
    J Med Chem; 2015 Jan; 58(2):577-87. PubMed ID: 25470204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A high-throughput cell-based assay pipeline for the preclinical development of bacterial DsbA inhibitors as antivirulence therapeutics.
    Verderosa AD; Dhouib R; Hong Y; Anderson TK; Heras B; Totsika M
    Sci Rep; 2021 Jan; 11(1):1569. PubMed ID: 33452354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective Binding of Small Molecules to Vibrio cholerae DsbA Offers a Starting Point for the Design of Novel Antibacterials.
    Wang G; Mohanty B; Williams ML; Doak BC; Dhouib R; Totsika M; McMahon RM; Sharma G; Zheng D; Bentley MR; Ka-Yan Chin Y; Horne J; Chalmers DK; Heras B; Scanlon MJ
    ChemMedChem; 2022 Mar; 17(6):e202100673. PubMed ID: 34978144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Four structural subclasses of the antivirulence drug target disulfide oxidoreductase DsbA provide a platform for design of subclass-specific inhibitors.
    McMahon RM; Premkumar L; Martin JL
    Biochim Biophys Acta; 2014 Aug; 1844(8):1391-401. PubMed ID: 24487020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative sequence, structure and redox analyses of Klebsiella pneumoniae DsbA show that anti-virulence target DsbA enzymes fall into distinct classes.
    Kurth F; Rimmer K; Premkumar L; Mohanty B; Duprez W; Halili MA; Shouldice SR; Heras B; Fairlie DP; Scanlon MJ; Martin JL
    PLoS One; 2013; 8(11):e80210. PubMed ID: 24244651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure analysis of the extracellular domain reveals disulfide bond forming-protein properties of Mycobacterium tuberculosis Rv2969c.
    Wang L; Li J; Wang X; Liu W; Zhang XC; Li X; Rao Z
    Protein Cell; 2013 Aug; 4(8):628-40. PubMed ID: 23828196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small molecule inhibitors of disulfide bond formation by the bacterial DsbA-DsbB dual enzyme system.
    Halili MA; Bachu P; Lindahl F; Bechara C; Mohanty B; Reid RC; Scanlon MJ; Robinson CV; Fairlie DP; Martin JL
    ACS Chem Biol; 2015 Apr; 10(4):957-64. PubMed ID: 25603425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal structure of the dithiol oxidase DsbA enzyme from proteus mirabilis bound non-covalently to an active site peptide ligand.
    Kurth F; Duprez W; Premkumar L; Schembri MA; Fairlie DP; Martin JL
    J Biol Chem; 2014 Jul; 289(28):19810-22. PubMed ID: 24831013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel strategies in the war against antibiotic resistance.
    Cascioferro S; Parrino B; Carbone D; Pecoraro C; Diana P
    Future Med Chem; 2021 Mar; 13(6):529-531. PubMed ID: 33467930
    [No Abstract]   [Full Text] [Related]  

  • 14. Intriguing conformation changes associated with the trans/cis isomerization of a prolyl residue in the active site of the DsbA C33A mutant.
    Ondo-Mbele E; Vivès C; Koné A; Serre L
    J Mol Biol; 2005 Apr; 347(3):555-63. PubMed ID: 15755450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel benzofuran and benzothiophene biphenyls as inhibitors of protein tyrosine phosphatase 1B with antihyperglycemic properties.
    Malamas MS; Sredy J; Moxham C; Katz A; Xu W; McDevitt R; Adebayo FO; Sawicki DR; Seestaller L; Sullivan D; Taylor JR
    J Med Chem; 2000 Apr; 43(7):1293-310. PubMed ID: 10753467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of the Thioredoxin Partner of Vitamin K Epoxide Reductase in Mycobacterial Disulfide Bond Formation.
    Ke N; Landeta C; Wang X; Boyd D; Eser M; Beckwith J
    J Bacteriol; 2018 Aug; 200(16):. PubMed ID: 29784887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, in vitro urease inhibitory potential and molecular docking study of benzofuran-based-thiazoldinone analogues.
    Taha M; Rahim F; Ullah H; Wadood A; Farooq RK; Shah SAA; Nawaz M; Zakaria ZA
    Sci Rep; 2020 Jun; 10(1):10673. PubMed ID: 32606439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis and biological evaluation of novel benzofuran derivatives as potent LSD1 inhibitors.
    Zhang X; Huang H; Zhang Z; Yan J; Wu T; Yin W; Sun Y; Wang X; Gu Y; Zhao D; Cheng M
    Eur J Med Chem; 2021 Aug; 220():113501. PubMed ID: 33945992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure of TcpG, the DsbA protein folding catalyst from Vibrio cholerae.
    Hu SH; Peek JA; Rattigan E; Taylor RK; Martin JL
    J Mol Biol; 1997 Apr; 268(1):137-46. PubMed ID: 9149147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The uncharged surface features surrounding the active site of Escherichia coli DsbA are conserved and are implicated in peptide binding.
    Guddat LW; Bardwell JC; Zander T; Martin JL
    Protein Sci; 1997 Jun; 6(6):1148-56. PubMed ID: 9194175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.